Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jeannine Guenther"'
Autor:
Mike O Becker, Marius M. Hoeper, A. Rose, Jeannine Guenther, Wolfgang M. Kuebler, Ivo Lukitsch, Duska Dragun, Maik Gollasch, Christoph Tabeling, Anja A. Kühl, Marissa Kutsche, Henning Tiede, Nils Nickel, Hossein Ardeschir Ghofrani, A. Kill, Ralph T. Schermuly, Gerd R Burmester, Harald Heidecke, Gabriela Riemekasten, Martin Witzenrath, Sebastian Bock
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 190:808-817
Rationale: Systemic sclerosis (SSc)-associated pulmonary arterial hypertension (PAH) portends worse outcome than other forms of PAH. Vasoconstrictive and vascular remodeling actions of endothelin (ET) 1 and angiotensin (Ang) II via endothelin recepto
Publikováno v:
Annals of the Rheumatic Diseases. 73:574.3-574
Background Functional autoantibodies against the angiotensin II receptor type 1 (AT1R) and the endothelin receptor type A (ETAR) have been identified in patients suffering from systemic sclerosis (SSc) [1]. Objectives Aim of the study was to validate
Autor:
Robert L. Wortmann, Ralph H. Schumacher, William A. Palo, Nancy Joseph-Ridge, Michael A. Becker, Patricia A. McDonald, Daniel Flores, Roderick J. Halbert, Jeannine Guenther, Kate Zhong, Pierre N. Tarcot, Margaret C. Minkwitz, Nancy A. Devine, Jacobo Mintzer
Publikováno v:
The Consultant Pharmacist. 21:76-77
Autor:
Harald Heidecke, A. Kill, Jeannine Guenther, Duska Dragun, Mike O Becker, Gabriela Riemekasten
Publikováno v:
Annals of the Rheumatic Diseases. 72:A72.1-A72
Background and Objectives SSc is a prototypic multiorgan disease characterised by vascular damage, autoimmunity and fibrosis with still unkown aetiology. Recently identified functional autoantibodies simultaneously targeting the angiotensin-II type-1
Publikováno v:
Anti-cancer drugs. 7(7)
The effects of diallyl sulfide (DAS) and diallyl disulfide (DADS) on cisplatin-induced changes in glutathione (GSH) and glutathione-S-transferase (GST) activity in rat liver and kidney was investigated. Cisplatin treatment significantly (p < 0.05) de
Autor:
Jeannine Guenther, Duska Dragun, Mike O Becker, Harald Heidecke, Gabriela Riemekaste, A. Kill
Publikováno v:
Annals of the Rheumatic Diseases. 71:A39.1-A39
Background Autoantibodies that target the angiotensin-II type-1 receptor (AT1R-Abs) and the endothelin-1 receptor type A (ETAR-Abs) were recently identified in systemic sclerosis (SSc). They showed strong association with clinical symptoms such as va